Therefore, the efforts made so far to reduce breast cancer progress aim to suppress the synthesis of endogenous estrogen or to block ERα, through the use of selective estrogen modulators (SERMs), among which tamoxifen stands out (3). Here, ESR1 is linked to breast cancer.